Cutting edge: blockade of the CD28/B7 costimulatory pathway inhibits intestinal allograft rejection mediated by CD4+ but not CD8+ T cells

KA Newell, G He, Z Guo, O Kim, GL Szot… - The Journal of …, 1999 - journals.aai.org
KA Newell, G He, Z Guo, O Kim, GL Szot, I Rulifson, P Zhou, J Hart, JR Thistlethwaite…
The Journal of Immunology, 1999journals.aai.org
The effect of blocking the CD28/B7 costimulatory pathway on intestinal allograft rejection
was examined in mice. Murine CTLA4Ig failed to prevent the rejection of allografts
transplanted into wild-type or CD4 knockout (KO) mice but did inhibit allograft rejection by
CD8 KO recipients. This effect was associated with decreased intragraft mRNA for IFN-γ and
TNF-α and increased mRNA for IL-4 and IL-5. This altered pattern of cytokine production
was not observed in allografts from murine CTLA4Ig-treated CD4 KO mice. These data …
Abstract
The effect of blocking the CD28/B7 costimulatory pathway on intestinal allograft rejection was examined in mice. Murine CTLA4Ig failed to prevent the rejection of allografts transplanted into wild-type or CD4 knockout (KO) mice but did inhibit allograft rejection by CD8 KO recipients. This effect was associated with decreased intragraft mRNA for IFN-γ and TNF-α and increased mRNA for IL-4 and IL-5. This altered pattern of cytokine production was not observed in allografts from murine CTLA4Ig-treated CD4 KO mice. These data demonstrate that blockade of the CD28/B7 pathway has different effects on intestinal allograft rejection mediated by CD4+ and CD8+ T cells and suggest that these T cell subsets have different costimulatory requirements in vivo. The results also suggest that the inhibition of CD4+ T cell-mediated allograft rejection by CTLA4Ig may be related to down-regulation of Th1 cytokines and/or up-regulation of Th2 cytokines.
journals.aai.org